President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...

Trump signed an executive order on April 18, 2026, directing the FDA and DEA to fast-track research and approval of ibogaine ...

The order aims to accelerate research and approval of psychedelic-based therapies to help treat mental health conditions ...

The order will open the door for more research into psychedelic drugs, including ibogaine, sources told CBS News earlier this ...

(Corrects name of advocacy group to Veterans Exploring Treatment Solutions in paragraph 19) By Jacob Bogage WASHINGTON, April ...

Proponents of the order, including a former Navy SEAL from Long Island who founded a nonprofit that helps facilitate ...

President Trump on Saturday signed an executive order to expedite research into the psychedelic ibogaine – a drug championed ...

This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, ...

WASHINGTON — The Department of Veterans Affairs will launch its first clinical study since the 1960s into the effectiveness of psychedelic drugs as a treatment for post-traumatic stress disorder, the ...

Ibogaine is used in Mexico and the Caribbean to treat depression, anxiety, addiction and brain trauma.

From spiritual healing to psychedelics to narrative work, recommendations for treating trauma and PTSD are everywhere online. You’ll find them in Instagram reels, wellness podcasts, and posts from ...

Experiencing trauma can sometimes lead to post-traumatic stress disorder (PTSD). This serious mental health condition is marked by changes in mood, intrusive memories, avoidant behavior, and a ...